Investigation of chiral active substances
Table of contents
This guideline applies to human and veterinary medicines.
|Keywords||Chirality, stereogenic centre, isomerism, stereoisomers, enantiomer, diastereoisomers, racemat|
|Description||This document intends to explain the requirements for studies of chiral active substances during the development of a medicinal product. It considers active substances with one or more stereogenic centres which display chirality but not constitutional isomerism or cis/trans isomerism.|